Example: Heart Attack

Clinical Trials Sponsored by Zambon SpA

Total 24 results

NCT04229303

Completed

Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

Conditions: Allergic Bronchopulmonary Aspergillosis
NCT03994328

Recruiting

An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD

Conditions: Parkinson's Disease
NCT03987750

Withdrawn

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

Conditions: Dyskinesia, Drug-Induced; Parkinson Disease
NCT03887221

Not yet recruiting

A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in Healthy Adult Chinese Volunteers

Conditions: Healthy
NCT03881371

Recruiting

A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa

Conditions: Parkinson Disease
NCT03881163

Completed

A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese Healthy Volunteers

Conditions: Respiratory Tract Disorders
NCT03843541

Completed

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Conditions: Respiratory Tract Diseases; Abnormal Mucus Secretions
NCT03841604

Active, not recruiting

Effect of Safinamide on Parkinson's Disease Related Chronic Pain

Conditions: Idiopathic Parkinson Disease
NCT03753763

Completed

Safinamide for Multiple System Atrophy (MSA)

Conditions: Multiple System Atrophy
NCT03460704

Recruiting

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium (PROMIS II)

Conditions: Non Cystic Fibrosis Bronchiectasis
NCT03093974

Active, not recruiting

Long Term Efficacy and Safety of Inhaled Colistimethate Sodium in Bronchiectasis Subjects With Chronic Pseudomonas Aeruginosa Infection.

Conditions: Non Cystic Fibrosis Bronchiectasis
NCT02994342

Completed

Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness

Conditions: Vaginal Dryness
NCT02631941

Completed

Clinical Study to Evaluate Z7200 Pharmacokinetics Profile

Conditions: Asthma
NCT02495831

Completed

Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers

Conditions: Healthy
NCT02265224

Completed

Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC)

Conditions: the Study Has Been Performed in Healthy Subjects
NCT02237508

Completed

A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers

Conditions: Asthma
NCT02227394

Completed

Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

Conditions: Asthma; Asthma Chronic; Asthma Bronchial; Asthmatic
NCT00639496

Completed

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)

Conditions: Pulmonary Fibrosis
NCT03216304

Completed

Safinamide Steady State Interaction With Rosuvastatin

Conditions: Healthy
NCT00205647

Completed

Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis

Conditions: Chronic Bronchitis
NCT04110587

Completed

Hyaluronic Acid Evaluation as Adjuvant to Temporomandibular Joint Arthroscopy

Conditions: Temporomandibular Joint Disc Displacement; Temporomandibular Joint Disorders
NCT03830190

Recruiting

Cost-effectiveness of Nursing Interventions for Patients With PD

Conditions: Parkinson Disease
NCT00184977

Completed

COPD on Primary Care Treatment (COOPT)

Conditions: Pulmonary Disease, Chronic Obstructive; Lung Diseases, Obstructive; Bronchitis, Chronic
NCT02250729

Unknown status

Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure

Conditions: Neuromuscular Blocking Agents Anaphylaxis